Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1993-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.90.5.1746PMID 8383326PMCID PMC45956
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification and characterization of the neu/erb B2 ligand-growth factor from bovine kidney.

  1992cited by this paper
• Expression of the c-erbB-3 protein in normal human adult and fetal tissues.

  1992cited by this paper
• Identification of Heregulin, a Specific Activator of p185erbB2

  1992cited by this paper
• Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit.

  1992cited by this paper
• Colorectum cell-derived growth factor (CRDGF) is homologous to amphiregulin, a member of the epidermal growth factor family.

  1992cited by this paper
• Characterization of a neu/c-erbB-2 protein-specific activating factor.

  1991cited by this paper
• An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system.

  1991cited by this paper
• Epidermal growth factor (EGF) receptor T669 peptide kinase from 3T3-L1 cells is an EGF-stimulated "MAP" kinase.

  1991cited by this paper
• Growth factors and cancer.

  1991cited by this paper
• Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

  1990cited by this paper
• The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity

  1990cited by this paper
• Molecular cloning and expression of an additional epidermal growth factor receptor-related gene.

  1990cited by this paper
• Progress in growth factor research editorial

  1989cited by this paper
• Novel putative receptor tyrosine kinase encoded by the melanoma-inducing Tu locus in Xiphophorus

  1989cited by this paper
• Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.

  1989cited by this paper
• Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts.

  1989cited by this paper
• All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor.

  1989cited by this paper
• Ligand-independent tyrosine phosphorylation of EGF receptor and the erbB-2/neu proto-oncogene product is induced by hyperosmotic shock.

  1989cited by this paper
• Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation.

  1989cited by this paper
• Release of a phorbol ester-induced mitogenic block by mutation at Thr-654 of the epidermal growth factor receptor

  1988cited by this paper
• Chicken epidermal growth factor (EGF) receptor: cDNA cloning, expression in mouse cells, and differential binding of EGF and transforming growth factor alpha

  1988cited by this paper
• The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.

  1988cited by this paper
• EGF‐stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions.

  1988cited by this paper
• Overexpression of the EGF receptor‐related proto‐oncogene erbB‐2 in human mammary tumor cell lines by different molecular mechanisms.

  1987cited by this paper
• Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.

  1987cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.

  1985cited by this paper
• Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

  1984cited by this paper

• Injury-induced Neuregulin-EGFR signaling from muscle mobilizes stem cells for whole-body regeneration in Acoels.

  2025cites this paper
• Gastrin-Releasing Peptide Receptors Stimulate MAPK-Mediated Growth of Lung Cancer Cells by Transactivating HER4 in a Neuregulin-1, MAP Kinase-Dependent Manner Requiring Activation of the ROS-System

  2025cites this paper
• EGFR activation and conformational "convergence": an emerging allosteric model from cancer mutations.

  2025cites this paper
• Targeting erbB Pathways in Breast Cancer: Dual Kinase Inhibition for Brain Metastasis and Prevention of p185HER2/Neu Tumor Development

  2024cites this paper
• Structural dynamics of the active HER4 and HER2/HER4 complexes is finely tuned by different growth factors and glycosylation

  2024influential citation
• Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives

  2024cites this paper
• HER4 is a high affinity dimerization partner for all EGFR/HER/ErbB-family proteins

  2024cites this paper
• The Multiple Functions of HB-EGF in Female Reproduction and Related Cancer: Molecular Mechanisms and Targeting Strategies

  2024cites this paper
• The impact of nitric oxide on HER family post-translational modification and downstream signaling in cancer

  2024cites this paper
• Identification of Biomarkers and Prognostic Analysis for Endometrial Cancer Patients Based on the ERBB Family

  2024cites this paper
• Structural dynamics of the active HER4 and HER2/HER4 complexes is finely tuned by different growth factors and glycosylation

  2024influential citation
• Zipper-Confined DNA Nanoframe for High-Efficient and High-Contrast Imaging of Heterogeneous Tumor Cell.

  2024cites this paper
• Injury-induced Neuregulin-ErbB signaling from muscle mobilizes stem cells for whole-body regeneration in Acoels

  2024cites this paper
• Monoclonal antibodies in breast cancer: a critical appraisal.

  2023cites this paper
• Structural arrangement of the active back-to-back dimer in N-glycosylated ErbB receptors is regulated by heterodimerization

  2023cites this paper
• HER2-Low Breast Cancer: Current Landscape and Future Prospects

  2023cites this paper
• Biased activation of the receptor tyrosine kinase HER2

  2023cites this paper
• ErbB4 in the brain: Focus on high grade glioma

  2022cites this paper
• ERBB Signaling Pathway in Cancer Stem Cells.

  2022cites this paper
• "Shedding" light on HER4 signaling in normal and malignant breast tissues.

  2022cites this paper
• Regulation of Signaling from the Epidermal Growth Factor Family.

  2022cites this paper
• Beyond HER2: Targeting the ErbB receptor family in breast cancer.

  2022cites this paper
• Shifting the Focus of Signaling Abnormalities in Colon Cancer

  2022cites this paper
• An ErbB Lineage Co-Regulon Harbors Potentially Co-Druggable Targets for Multimodal Precision Therapy in Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations

  2022cites this paper
• Cancer regulator EGFR-ErbB4 heterodimer is stabilized through glycans at the dimeric interface

  2022cites this paper
• Targeting HER2-positive breast cancer: advances and future directions

  2022cites this paper
• An extracellular receptor tyrosine kinase motif orchestrating intracellular STAT activation

  2022cites this paper
• A narrative review of ERBB2 in non-small cell lung carcinoma

  2022cites this paper
• The HER family as therapeutic targets in colorectal cancer.

  2022cites this paper
• EGFR Signaling in Lung Fibrosis

  2022cites this paper
• Defining Breast Cancer

  2021cites this paper
• The Association between ERBB4 Gene Polymorphism (SNP: Rs1972820g>A) and the Risk of Breast Cancer

  2021cites this paper
• ErbB4‐mediated regulation of vasculogenic mimicry capability in breast cancer cells

  2021cites this paper
• Glycosylation promotes the cancer regulator EGFR-ErbB2 heterodimer formation — molecular dynamics study

  2021cites this paper
• Source and Impact of the EGF Family of Ligands on Intestinal Stem Cells

  2021cites this paper
• A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors

  2021cites this paper
• HER-2 as a Prognostic and Predictive Biomarker in Cancer

  2021cites this paper
• The potential targeted drugs for fusion genes including NRG1 in pancreatic cancer.

  2021cites this paper
• Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme

  2021cites this paper
• Modulation of polycystic kidney disease by non-coding RNAs.

  2020cites this paper
• Diverse roles of epidermal growth factors receptors in oral and cutaneous canine melanomas

  2020cites this paper
• HER family in cancer progression: From discovery to 2020 and beyond.

  2020cites this paper
• Recent advances in HER2-targeted delivery for cancer therapy.

  2020cites this paper
• Coordinated dysregulation of cancer progression by the HER family and p21-activated kinases

  2020cites this paper
• ERBB2b mRNA isoform encodes a nuclear variant of the ERBB2 oncogene in breast cancer

  2020cites this paper
• Neuregulin, an Effector on Mitochondria Metabolism That Preserves Insulin Sensitivity

  2020cites this paper
• Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines

  2020cites this paper
• Mechanisms of ERBB3 Action in Human Neoplasia.

  2019cites this paper
• Neuregulin-1/ErbB Network: An Emerging Modulator of Nervous System Injury and Repair.

  2019cites this paper
• Decreased circulating ErbB4 ectodomain fragments as a read-out of impaired signaling function in amyotrophic lateral sclerosis.

  2019cites this paper
• Novel roles of ErbB3 receptor tyrosine kinase in vesicular trafficking

  2019influential citation
• Targeting Members of the Epidermal Growth Factor Receptor Family to Improve Response to Chemotherapy

  2019cites this paper
• Target HER four in breast cancer?

  2019cites this paper
• ErbB4 tyrosine kinase inhibition impairs neuromuscular development in zebrafish embryos

  2019cites this paper
• ERBB2-modulated ATG4B and autophagic cell death in human ARPE19 during oxidative stress

  2019cites this paper
• HER3 expression is enhanced during progression of lung adenocarcinoma without EGFR mutation from stage 0 to IA1

  2018cites this paper
• Analyse protéomique de la coordination dynamique par la protéine adaptatrice GRB2 des réseaux de signalisation cellulaire dans le cancer du sein HER2

  2018cites this paper
• Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response

  2018cites this paper
• Genomic alterations of ERBB receptors in cancer: clinical implications

  2017cites this paper
• Neuregulin-1 protects mouse cerebellum against oxidative stress and neuroinflammation.

  2017cites this paper
• SYSTEMAND METHOD TO INHIBIT HEREGULIN ACTIVATED PROCESSES AND OTHER METHODS USING SOLUBLE ERBB3 AND METHOD TO PRODUCE SOLUBLE ERBB3

  2017cites this paper
• 2 The Electronics of HER 2 / neu Positive Breast Cancer Cells

  2017cites this paper
• Association between ErbB4 single nucleotide polymorphisms and susceptibility to schizophrenia

  2017cites this paper
• The receptor tyrosine kinase Met and the protein tyrosine phosphatase PTPN 2 in breast cancer

  2017cites this paper
• Discovery of ERBB3 inhibitors for non-small cell lung cancer (NSCLC) via virtual screening

  2016cites this paper
• EGFR and HER2 signaling in breast cancer brain metastasis.

  2016cites this paper
• NTAK/neuregulin-2 secreted by astrocytes promotes survival and neurite outgrowth of neurons via ErbB3.

  2016cites this paper
• p85α promotes nucleolin transcription and subsequently enhances EGFR mRNA stability and EGF-induced malignant cellular transformation

  2016cites this paper
• Intrinsic HER4/4ICD transcriptional activation domains are required for STAT5A activated gene expression.

  2016cites this paper
• How to Build Up Adequate Prognostic Markers in the Molecular Biology Context of Breast Cancer

  2016cites this paper
• Investigation of a role for the endosomal deubiquitylase USP8 in cancer cell survival pathways

  2016cites this paper
• Cytotoxic effects of selenium conjugated trastuzumab on HER2+ breast cancer cell lines

  2015cites this paper
• The role of the EGFR and ERBB4 in acute pancreatitis

  2015cites this paper
• Regulation von Rezeptor-Tyrosinkinasen durch Opioide

  2015cites this paper
• Screening of three ERBB4 gene polymorphisms in a group of Turkish schizophrenia patients and controls / ERBB4 genindeki üç polimorfizmin bir Türk şizofreni hasta grubunda ve kontrollerde taranması

  2015cites this paper
• Meta‐analysis reveals no significant correlation between breast cancer survival and ErbB3 expression

  2015cites this paper
• Muc 4 Modulation of Ligand-Independent ErbB 2 Signaling

  2015cites this paper
• Soluble E-cadherin as a microenvironmental factor which enhances tumor progression

  2015cites this paper
• Dimerization drives EGFR endocytosis through two sets of compatible endocytic codes

  2015cites this paper
• The EGFR/ERBB Receptor Family

  2015cites this paper
• Association between ERBB4 gene polymorphism in the microRNA binding site and endometrial carcinoma risk

  2015influential citation
• Combinatorial treatment of lung cancer monolayer cells and their spheroids with tyrosine kinase inhibitors and Salinomycin

  2015cites this paper
• HER-2/fieu Testing Comes of Age

  2015cites this paper
• Regulated intramembrane proteolysis of NRG1 type III dediates postnatal peripheral myelination

  2015cites this paper
• Heparin Binding–Epidermal Growth Factor-Like Growth Factor for the Regeneration of Chronic Tympanic Membrane Perforations in Mice

  2015cites this paper
• Die Funktionen der Neureguline im Kortex und Muskel

  2014influential citation
• Heregulin in breast cancer: old story, new paradigm.

  2014cites this paper
• ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells

  2014cites this paper
• ERBB4 mutations in cancer and amyotrophic lateral sclerosis

  2014cites this paper
• Desmocollin-2 〔DSC 2 〕基因抑制人類肺癌細胞的增生與移動能力 = Desmocollin-2 〔DSC 2 〕Inhibit proliferation and migration abi

  2014cites this paper
• Régulation de l’activité transcriptionnelle des récepteurs des estrogènes (ER) par le récepteur à chimiokine CXCR4 et les récepteurs à activité tyrosine kinase ErbB2 et ErbB3

  2014cites this paper
• Expression of Erythroblastic Leukemia Viral Oncogene Homolog 2 (ERBB2) from Canine Mammary Tumor

  2014cites this paper
• Einfluss des Tyrosinkinase-Inhibitors Imatinib auf das ErbB3-Receptor Binding Protein1 (Ebp1) in der CML

  2014cites this paper
• Correlation between HER-2/neu(erbB-2) expression level and therapeutic effect of combination treatment with HERCEPTIN and chemotherapeutic agents in gastric cancer cell lines

  2014cites this paper
• Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors

  2014cites this paper
• Neuregulin signaling in pieces--evolution of the gene family.

  2014cites this paper
• Einfluss des Tyrosinkinase-Inhibitors Imatinib auf das ErbB3- Receptor Binding Protein1 (Ebp1) in der CML

  2014cites this paper
• Heparin-binding epidermal growth factor-like growth factor (HB-EGF) and proteolytic processing by a disintegrin and metalloproteinases (ADAM): a regulator of several pathways.

  2014cites this paper
• Desmocollin-2 〔DSC 2 〕Inhibit proliferation and migration ability in human lung cancer cells

  2014cites this paper